Virtual Research Series on Clonal Hematopoiesis

Clonal hematopoiesis in cancer patients: predictors of clonal expansion and intervention strategies

Date: Tuesday, May 26, 2020
Time: 10:30 am - 11:15 am EST 
Kelly Bolton, MD, PhD, Memorial Sloan Kettering Cancer Center
Session 1: Genetics and Guidelines for Screening and Monitoring
Moderator: Omar Abdel-Wahab, MD

Clonal hematopoiesis and cardiovascular disease insights from simultaneous germline and somatic genetic analyses

Date: Tuesday, May 26, 2020
Time: 11:15 am – 12:00 pm EST 
Pradeep Natarajan, MD, Massachusetts General Hospital
Session 1: Genetics and Guidelines for Screening and Monitoring
Moderator: Omar Abdel-Wahab, MD

Natural and CRISPR-generated models of clonal hematopoiesis biology and interventions in non-human primates

Date: Wednesday, May 27, 2020
Time: 10:30 am - 11:15 am EST 
Cynthia Dunbar, MD, National Institutes of Health
Session 2: Implications of CH Beyond Leukemia
Moderator: Benjamin Ebert, MD, PhD

Clonal hematopoiesis and non-malignant diseases

Date: Wednesday, May 27, 2020
Time: 11:15 am - 12:00 pm EST
Sidd Jaiswal, MD, PhD, Stanford University
Session 2: Implications of CH Beyond Leukemia
Moderator: Benjamin Ebert, MD, PhD

Therapeutic targeting of CH; how do we proceed?

Date: Thursday, June 4, 2020
Time: 8:30 am - 9:15 am EST 
Ross Levine, MD, Memorial Sloan Kettering Cancer Center
Session 3: Potential Therapeutic Interventions
Moderator: David Steensma, MD

Crossing the Threshold to Abnormality: A Holistic Analysis of Very Rare Clonal Hematopoiesis

Date: Thursday, June 4, 2020
Time: 9:15 am - 10:00 am EST 
Todd Druley, MD, PhD, Washington University
Session 3: Potential Therapeutic Interventions
Moderator: David Steensma, MD